Vapotherm Access (f/k/a/ HGE Health) has developed a clinical services platform that enables Providers and their COPD patients to improve a patient’s quality of life and respond to early changes their day-to-day symptoms. We've built upon clinical protocols developed by Dr. Gerard Criner of Temple University and supported by his 14 years of research focused on finding a better way to provide care for a geographically and socio-economically diverse COPD patient population. Vapotherm Access' clinically validated care standards and technology sit at the center of the healthcare ecosystem and deliver better care faster, which results in improved outcomes at a much lower cost. Vapotherm Access' patients have more symptom-free days, their Providers are more engaged, and at-risk institutions experience a more than 60% reduction of utilization costs and improved financial levers that result in a consistent 5:1 ROI. Contact Us | 888-410-6230 | [email protected]